Supply Chain

On May 27, the U.S. Food and Drug Administration granted accelerated approval to a new treatment for primary biliary cholangitis — a chronic liver disease that causes bile ducts in the liver to become inflamed, which can damage cells overtime…

A recent blog post in the reSOURCEs section of the HealthTrust public website discusses how the new UDI system will affect healthcare operations.

One of California's largest private groups of oncologists opposes the new Medicare proposal that would involve senior citizens in payment experiments involving chemotherapy.

The affordability of antibiotics is fueling drug resistance, leading to a legitimate threat of superbugs, Ezekiel Emanuel, MD, PhD, wrote in an op-ed for The Washington Post.

While most people express concern over high drug costs, raising the price on generic injectable drugs could help prevent dangerous shortages, according to a column by health economist Austin Frakt in The New York Times.

An increasing number of medical device and pharmaceutical companies are offering a money-back guarantee to payers and providers for products that do not work as intended, reports STAT.

The attorneys general of Washington state and California have filed lawsuits against Johnson & Johnson, claiming the healthcare giant misinterpreted the severe risks of vaginal mesh implants for years, according to CBS News.

A federal judge has ordered Washington state's Medicaid provider to cover expensive drugs that can cure hepatitis C infections for all patients with the liver-destroying disease, not just the sickest.

The price of a life-saving drug that can reverse an opioid overdose is rising dramatically, just as healthcare officials push to make the drug more available in clinics, homes and schools.

The electrodes for medical devices market will reach $1.45 billion by 2019, according to a report from Transparency Market Research.